Cargando…
Redox Signaling as a Therapeutic Target to Inhibit Myofibroblast Activation in Degenerative Fibrotic Disease
Degenerative fibrotic diseases encompass numerous systemic and organ-specific disorders. Despite their associated significant morbidity and mortality, there is currently no effective antifibrotic treatment. Fibrosis is characterized by the development and persistence of myofibroblasts, whose unregul...
Autores principales: | Sampson, Natalie, Berger, Peter, Zenzmaier, Christoph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950649/ https://www.ncbi.nlm.nih.gov/pubmed/24701562 http://dx.doi.org/10.1155/2014/131737 |
Ejemplares similares
-
Therapeutic Targeting of Redox Signaling in Myofibroblast Differentiation and Age-Related Fibrotic Disease
por: Sampson, Natalie, et al.
Publicado: (2012) -
Dickkopf-related protein 3 promotes pathogenic stromal remodeling in benign prostatic hyperplasia and prostate cancer
por: Zenzmaier, Christoph, et al.
Publicado: (2013) -
Towards an anti-fibrotic therapy for scleroderma: targeting myofibroblast differentiation and recruitment
por: Leask, Andrew
Publicado: (2010) -
Myofibroblast–Macrophage Interactions Turn Sour in Fibrotic
Lungs
por: Garantziotis, Stavros
Publicado: (2021) -
Fibrotic Myofibroblasts Manifest Genome-Wide Derangements of Translational Control
por: Larsson, Ola, et al.
Publicado: (2008)